Kiniksa Pharmaceuticals International, plc Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Kiniksa Pharmaceuticals International, plc Return On Equity for the quarter ending September 30, 2024 was -2.08 %, a 24.6% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2023 was 3.42 %, a 94.9% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2022 was 66.7 %.
  • Kiniksa Pharmaceuticals International, plc annual Return On Equity for 2021 was -69.8 %, a 21.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 3.42 -63.3 -94.9% Jan 1, 2023 Dec 31, 2023
2022 66.7 +136 Jan 1, 2022 Dec 31, 2022
2021 -69.8 -12.5 -21.7% Jan 1, 2021 Dec 31, 2021
2020 -57.3 +3.84 +6.28% Jan 1, 2020 Dec 31, 2020
2019 -61.1 -11.7 -23.6% Jan 1, 2019 Dec 31, 2019
2018 -49.5 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.